Search Within

Tiffany A Traina

Formats
  1. Meeting Abstract (140)
  2. Journal Article (96)
  3. Book Section (8)
  4. Review (8)
  5. Book Whole (2)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Breast Medicine Service (256)
  2. Department of Medicine (256)
  3. Solid Tumor Oncology Division (256)
  4. Survivorship Research (256)
  5. Epidemiology and Biostatistics (102)
  6. Biostatistics Service (87)

More Groups

People
  1. Clifford Hudis (95)
  2. Sujata Patil (62)
  3. Ayca Gucalp (59)
  4. Larry Norton (56)
  5. Maura Dickler (34)
  6. Diana Lake (33)

More People

Years
  1. 2025 (9)
  2. 2024 (16)
  3. 2023 (8)
  4. 2022 (13)
  5. 2021 (17)
  6. 2020 (16)

More Years

Publications
  1. Journal of Clinical Oncology (79)
  2. Cancer Research (44)
  3. Breast Cancer Research and Treatment (16)
  4. Annals of Oncology (14)
  5. Clinical Cancer Research (11)
  6. Clinical Breast Cancer (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (80)
  2. American Association for Cancer Research (55)
  3. Springer (33)
  4. Elsevier Inc. (23)
  5. Oxford University Press (17)
  6. Future Medicine (5)

More Publishers

Results (256)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of BRCA1/2 mutation status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer
    Meeting Abstract

    Isakoff, S. J.; Goss, P. E.; Mayer, E. L.; Traina, T.; Carey, L. A.; Krag, K. J.; Liu, M. C.; Rugo, H.; Stearns, V.; Come, S.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Evaluation of the prognostic significance of androgen receptor (AR) expression in relation to ER expression in breast cancer (BC)
    Meeting Abstract

    Gucalp, A.; Datko, F. M.; Patil, S.; Hedvat, C. V.; Kalinsky, K.; Hudis, C. A.; Traina, T. A.; Moynahan, M. E.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Novel and targeted therapies
    Book Section

    Zauderer, M. G.; Traina, T. A.; Lichtman, S. M.
    In Naeim, A.; Reuben, D. B.; Ganz, P. A. (Eds.) Management of Cancer in the Older Patient (2012)

    Fulltext@MSK | Save
  • Intact RB1 pathway is associated with favorable distant metastasis-free survival in triple negative breast cancer
    Meeting Abstract

    Gupta, G. P.; Wen, Y. H.; Rogers, K.; Akram, M.; Gucalp, A.; Traina, T.; Powell, S. N.; Brogi, E.; Ho, A. Y.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • EGFR and P53 expression in androgen receptor (AR)-positive, triple negative breast cancer (TNBC)
    Meeting Abstract

    Gucalp, A.; Gupta, G.; Patil, S.; Wen, Y. H.; Akram, M.; Brogi, E.; Powell, S.; Ho, A.; Hudis, C. A.; Traina, T. A.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy
    Journal Article

    Ho, A. Y.; Gupta, G.; King, T. A.; Perez, C. A.; Patil, S. M.; Rogers, K. H.; Wen, Y. H.; Brogi, E.; Morrow, M.; Hudis, C. A.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • The androgen receptor in breast cancer: Biology and treatment considerations
    Journal Article

    Gucalp, A.; Traina, T. A.
    Current Breast Cancer Reports (2012)

    Fulltext@MSK | Save
  • Norton-Simon hypothesis
    Book Section

    Traina, T. A.; Norton, L.
    In Schwab, M. (Eds.) Encyclopedia of Cancer. 3rd ed (2011)

    Fulltext@MSK | Save
  • Log-kill hypothesis
    Book Section

    Traina, T. A.; Norton, L.
    In Schwab, M. (Eds.) Encyclopedia of Cancer. 3rd ed (2011)

    Fulltext@MSK | Save